Department of Neurology, Osmania Medical College, Hyderabad, Telangana, India
Mini Review
New therapeutic strategies for Alzheimer’s disease
Author(s): Mayank Jain*
Alzheimer's disease (AD) is an ever-evolving decay of cerebrum
capability, at first portrayed by mental shortages, with loss of
ongoing memory and language capacity, disability of direction,
critical thinking, and unique reasoning. While existing medication
medicines assist with diminishing the side effects of AD and work on
individuals' personal satisfaction, they neither sluggish its movement
nor fix it. As of now, designated drug conveyance to the focal sensory
system (CNS), for treatment of AD, is bound by the difficulties
presented by blood-mind interfaces encompassing the CNS,
restricting the bioavailability of therapeutics. Among new systems to
defeat these impediments and effectively convey medications to the
CNS, nanoparticles (NPs) can beat these constraints, offering new
helpful assignments in term of driving medications to cr.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 